IRIS
TURNATURI, RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.931
EU - Europa 1.580
AS - Asia 982
AF - Africa 268
SA - Sud America 245
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.012
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.865
IT - Italia 861
SG - Singapore 507
CN - Cina 326
IE - Irlanda 232
BR - Brasile 218
CI - Costa d'Avorio 167
DE - Germania 122
UA - Ucraina 111
SN - Senegal 79
RU - Federazione Russa 67
CA - Canada 56
FR - Francia 39
GB - Regno Unito 23
KR - Corea 21
ES - Italia 20
FI - Finlandia 20
VN - Vietnam 20
JP - Giappone 19
IN - India 17
SE - Svezia 16
BE - Belgio 15
PL - Polonia 11
TR - Turchia 11
BD - Bangladesh 10
CZ - Repubblica Ceca 9
IQ - Iraq 9
NL - Olanda 9
UZ - Uzbekistan 8
AR - Argentina 7
AT - Austria 7
MX - Messico 7
PK - Pakistan 7
AU - Australia 5
EC - Ecuador 5
GR - Grecia 5
HK - Hong Kong 5
HU - Ungheria 5
TN - Tunisia 5
VE - Venezuela 5
ZA - Sudafrica 5
CO - Colombia 4
EG - Egitto 4
LB - Libano 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
IL - Israele 3
SA - Arabia Saudita 3
CL - Cile 2
DO - Repubblica Dominicana 2
KE - Kenya 2
KZ - Kazakistan 2
NG - Nigeria 2
PY - Paraguay 2
AZ - Azerbaigian 1
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
ID - Indonesia 1
IR - Iran 1
LT - Lituania 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
UY - Uruguay 1
Totale 6.012
Salva come PNG Salva come JPEG
Città #
Houston 486
Santa Clara 480
Chandler 451
Singapore 284
Catania 245
Dublin 230
Chicago 215
Abidjan 167
Boardman 115
Ashburn 106
Jacksonville 84
Dakar 79
Civitanova Marche 70
Bremen 62
Andover 61
Cambridge 60
Lawrence 60
Nanjing 57
Hefei 45
Rome 38
Naples 36
The Dalles 35
Columbus 34
Council Bluffs 33
Des Moines 33
Toronto 33
Wilmington 28
Beijing 27
Munich 26
Seoul 21
San Giovanni la Punta 18
São Paulo 18
Los Angeles 17
Messina 17
Shenyang 16
Brussels 14
Saint Petersburg 14
Changsha 13
Dong Ket 13
Jiaxing 12
Moscow 12
Paternò 12
Salerno 12
Tokyo 12
San Mateo 11
Falls Church 10
Nanchang 10
Ottawa 10
Turku 10
New York 9
Pune 9
Rimini 9
Tianjin 9
Grafing 8
Madrid 8
Milan 8
Pozzallo 8
Bologna 7
Brno 7
Cagliari 7
Jinan 7
Siracusa 7
Washington 7
Aci Catena 6
Baghdad 6
Fortaleza 6
Fukuoka 6
Hebei 6
Lappeenranta 6
Lentini 6
Ningbo 6
Palermo 6
Rio de Janeiro 6
San Gregorio di Catania 6
Seattle 6
Vittoria 6
Warsaw 6
Belo Horizonte 5
Budapest 5
Dearborn 5
Froges 5
Gravina di Catania 5
Heidelberg 5
Marseille 5
Misterbianco 5
Norwalk 5
Paris 5
Randazzo 5
Tashkent 5
Bari 4
Bronte 4
Brooklyn 4
Civitavecchia 4
Fremont 4
Groningen 4
Hanoi 4
Helsinki 4
Lahore 4
Melbourne 4
Orzivecchi 4
Totale 4.250
Salva come PNG Salva come JPEG
Nome #
Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation 380
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 213
Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells 142
Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphans, analogs of LP2, as novel MOR ligands 127
Influenza del N-sostituente della (–)-cis-N-Normetazocina nella modulazione del profilo funzionale al MOR, DOR e KOR: da agonista ad antagonista attraverso ligandi misti agonisti/antagonisti 120
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 114
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 111
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands 100
Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists 99
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 99
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 96
From plant to bench: natural products as source for analgesic drug development. 96
(+)-and (−)-Phenazocine enantiomers: evaluation of their dual opioid agonist/σ1 antagonist properties and antinociceptive effects 93
Intercellular communication and ion channels in neuropathic pain chronicization 93
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 91
LP2 e 2S-LP2: agonisti biased dual target MOR/DOR nel trattamento del dolore cronico 89
Development of novel LP1-based analogues with enhanced delta opioid receptor profile 87
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 87
In Vitro Antioxidant Activity and In Vivo Topical Efficacy of Lipid Nanoparticles Co-Loading Idebenone and Tocopheryl Acetate 87
The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling 87
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review 85
Tuning Properties for Blood-Brain Barrier Permeation: A Statistics-Based Analysis 84
The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment 83
ANTIALLODINIC AND ANTIHYPERALGESIC EFFECTS OF LP1, AN OPIOID MULTITARGET LIGAND, IN INFLAMMATORY AND NEUROPATHIC PAIN STATES 83
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 83
The benzomorphan-based compound LP1 is a central acting MOR agonist/DOR antagonist suitable for chronic pain treatment 82
Dual MOR/DOR agonist benzomorphan-based compounds for pain relief 80
A new Sigma-1 Receptor antagonist in Chronic Pain Treatment: (+)-2R/S-LP2 effects in inflammatory and neuropathic pain 79
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 79
Multitarget opioid ligands in pain relief: New players in an old game 77
Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand. 77
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 77
Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain 75
The Benzomorphan-Based Compound LP1 as Suitable Candidate for Pain Management 75
Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review 75
Evaluation of N-substituent structural variations in opioid receptor profile of LP1. 75
Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management 74
Repeated activation of delta opiod receptors counteracts nerve injury-induced TNF-α up-regulation in the sciatic nerve of rats with neuropathic pain: A possible correlation with delta opiod receptors-mediated antiallodinic effect. 74
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 74
Antiproliferative and Antioxidant Activity of Glycoconjugates of Dithiocarbamates and Their Copper(II) and Zinc(II) Complexes 73
Biotin-8-hydroxyquinoline conjugates and their metal complexes: Exploring the chemical properties and the antioxidant activity 73
Differential scanning calorimetry approach to investigate the transfer of the multitarget opioid analgesic LP1 to biomembrane model 73
Design and synthesis of trans-decahydroisoquinoline derivatives as new tramadol-like ligands 72
From agonist to antagonist profile in LP1 analogues through the introduction of different N-substituents in benzomorphan-based ligands 72
Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain 72
MOR/DOR targeting: an useful strategy in pain management 71
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 70
Progress in the development of more effective and safer analgesics for pain management 70
Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles 69
Design, synthesis, and biological evaluation of new hybrid MOR agonist/HDACi compounds: an innovative approach for persistent pain management 68
THE BENZOMORPHAN-BASED COMPOUND LP1 AS A MULTITARGET OPIOID LIGAND FOR CHRONIC PAIN TREATMENT 68
Sigma-1 Receptor Inhibition Reduces Mechanical Allodynia and Modulate Neuroinflammation in Chronic Neuropathic Pain 65
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 65
The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures 64
Synthesis and structure-activity relationships of (–)-cis-N-normetazocine-based LP1 derivatives 63
Modulation of opioid receptor profile of LP1 analogues through the introduction of different N-substituents 62
Idebenone: Novel strategies to improve its systemic and local efficacy 61
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 60
Resveratrol-loaded lipid nanocarriers: Correlation between in vitro occlusion factor and in vivo skin hydrating effect 55
Multitarget MOR/DOR antinociceptive ligands as useful profile in pain management: synthesis and pharmacological studies of 6,7-benzomorphan-based LP2 and its isomers 55
Simultaneous activation of mu and delta opioid receptors reduces allodynia and astrocytic connexin 43 in an animal model of neuropathic pain 54
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 53
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 53
Synthesis and structure-activity relationships of (-)-cis-N-Normetazocine-based LP1 derivatives 51
From Plant to Chemistry: Sources of Antinociceptive Non-Opioid Active Principles for Medicinal Chemistry and Drug Design 50
Dual-target ligands and pain: our experience 49
In Vitro Evaluation of Sunscreen Safety: Effects of the Vehicle and Repeated Applications on Skin Permeation from Topical Formulations 49
Solid lipid nanoparticles as carriers for the synthetic opioid lp2: Characterization and in vitro release 48
Design, Synthesis and biological evaluation of hybrid MOR agonist/ HDACi molecules as potential therapeutic agents for chronic pain treatment 47
Design, synthesis and biological evaluation of MOR agonist/HDACi hybrid compounds: a new potential therapeutic strategy for persistent pain management 47
THE BENZOMORPHAN-BASED LP1 IS A CENTRAL-ACTING MULTITARGET OPIOID LIGAND FOR CHRONIC PAIN TREATMENT 47
IDEBENONE LOADED LIPID NANOPARTICLES: EVALUATION OF IN VITRO ANTIOXIDANT ACTIVITY AND IN VIVO TOPICAL EFFECTS 46
Analgesici oppioidi 44
Hybrid MOR agonist/HDACi molecules as potential antinociceptive multi-target drugs: design, synthesis, and biological evaluation 43
MOR/DOR Dual-Target Approach: 2S-LP2 Effects in Inflammatory and Neuropathic Pain 43
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 41
Hybrid MOR agonist/HDACi molecules as potential new drugs for persistant pain management: design, synthesis and biological evaluation 39
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics for Pain Treatment 32
Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body 30
NEW BENZOMORPHAN-BASED LP1 LIGAND AS SUITABLE MIXED MOP/DOP RECEPTORS AGONIST FOR CHRONIC PAIN TREATMENT 30
NEW PLAYERS IN AN OLD GAME: Pharmacological Evaluation of the Benzomorphan-Based Compound LP1. Design and Synthesis of Conformationally Constrained Compounds as New Tramadol-like Candidates. 29
Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid 28
Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesia 25
Totale 6.281
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.523
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021349 13 17 35 21 93 13 41 6 35 10 34 31
2021/2022544 43 58 10 17 82 10 73 24 41 24 20 142
2022/20231.239 90 79 32 192 96 165 7 244 220 30 52 32
2023/2024721 33 102 43 32 53 193 35 55 2 23 106 44
2024/20252.298 53 340 113 188 442 307 187 97 125 143 150 153
2025/2026118 118 0 0 0 0 0 0 0 0 0 0 0
Totale 6.281